A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
מצבים רפואיים
Systemic Sclerosis
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Local Institution - 0035, Scottsdale, Arizona, United States
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Local Institution - 0001, Denver, Colorado, United States
Local Institution - 0069, Miami, Florida, United States
Emory University School of Medicine, Atlanta, Georgia, United States
Local Institution - 0139, Chicago, Illinois, United States
Local Institution - 0084, Worcester, Massachusetts, United States
Local Institution - 0034, Ann Arbor, Michigan, United States
Local Institution - 0037, Rochester, Minnesota, United States
Local Institution - 0082, Summit, New Jersey, United States
Local Institution - 0122, Cleveland, Ohio, United States
Local Institution - 0142, Philadelphia, Pennsylvania, United States
Local Institution - 0143, Pittsburgh, Pennsylvania, United States
Local Institution - 0002, Charleston, South Carolina, United States
Local Institution - 0074, Dallas, Texas, United States
Local Institution - 0144, Houston, Texas, United States
Local Institution - 0008, Seattle, Washington, United States
Local Institution - 0057, Leuven, Vlaams-Brabant, Belgium
Local Institution - 0080, Liège, Belgium
Local Institution - 0104, Halifax, Nova Scotia, Canada
Local Institution - 0088, Sherbrooke, Quebec, Canada
Local Institution - 0031, Strasbourg, Alsace, France
Local Institution - 0061, Toulouse, Haute-Garonne, France
Local Institution - 0049, Bordeaux, France
Local Institution - 0012, Bron, France
Local Institution - 0052, Paris, France
Local Institution - 0141, Rennes, France
Local Institution - 0046, Berlin, Germany
Local Institution - 0016, Cologne, Germany
Local Institution - 0028, Erlangen, Germany
Local Institution - 0042, Leipzig, Germany
Local Institution - 0032, München, Germany
Local Institution - 0033, Tübingen, Germany
Local Institution - 0038, Würzburg, Germany
Local Institution - 0103, Rome, Lazio, Italy
Local Institution - 0004, Milan, Milano, Italy
Local Institution - 0108, Pisa, Tuscany, Italy
Local Institution - 0106, Milan, Italy
Local Institution - 0026, Sapporo, Hokkaido, Japan
Local Institution - 0132, Yokohama, Kanagawa, Japan
Local Institution - 0137, Suita, Osaka, Japan
Local Institution - 0117, Bunkyo-ku, Tokyo, Japan
Local Institution - 0123, Fukuoka, Japan
Local Institution - 0136, Maebashi, Japan
Local Institution - 0118, Okayama, Japan
Local Institution - 0129, A Coruña, A Coruña [La Coruña], Spain
Local Institution - 0138, Barcelona, Catalunya [Cataluña], Spain
Local Institution - 0060, Barcelona, Spain
Local Institution - 0009, Málaga, Spain
Local Institution - 0047, Basel, Switzerland
Local Institution - 0068, Bern, Switzerland
Local Institution - 0078, Zurich, Switzerland
Local Institution - 0140, London, London, City of, United Kingdom
Local Institution - 0063, Leeds, West Yorkshire, United Kingdom
Local Institution - 0091, Sheffield, Yorkshire and the Humber, United Kingdom
Local Institution - 0059, London, United Kingdom
מובילי המחקר
Bristol-Myers Squibb
Study Director
Bristol-Myers Squibb